X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9094) 9094
Book Review (827) 827
Publication (769) 769
Book Chapter (24) 24
Conference Proceeding (16) 16
Magazine Article (13) 13
Trade Publication Article (3) 3
Book / eBook (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8774) 8774
humans (8620) 8620
hepacivirus - isolation & purification (6168) 6168
hepacivirus - genetics (4671) 4671
male (4353) 4353
female (4286) 4286
adult (3572) 3572
middle aged (3536) 3536
hepatitis c virus (3180) 3180
hepatitis c (2380) 2380
virology (2356) 2356
hepatitis c - virology (2162) 2162
genotype (2110) 2110
infection (1968) 1968
aged (1886) 1886
rna, viral - blood (1854) 1854
gastroenterology & hepatology (1647) 1647
hepacivirus - immunology (1616) 1616
hepatitis (1568) 1568
infectious diseases (1545) 1545
hepatitis c - epidemiology (1465) 1465
antiviral agents - therapeutic use (1371) 1371
prevalence (1353) 1353
hepatitis c, chronic - virology (1312) 1312
polymerase chain reaction (1298) 1298
rna (1270) 1270
hcv (1257) 1257
hepatitis c - diagnosis (1246) 1246
molecular sequence data (1203) 1203
health aspects (1171) 1171
hepatitis c, chronic - drug therapy (1157) 1157
hepacivirus - classification (1097) 1097
rna, viral - analysis (1026) 1026
virus diseases (970) 970
risk factors (964) 964
adolescent (948) 948
viral load (946) 946
interferon-alpha - therapeutic use (941) 941
interferon (920) 920
microbiology (907) 907
treatment outcome (888) 888
rna, viral - genetics (884) 884
base sequence (877) 877
hepacivirus - physiology (873) 873
infections (861) 861
hepatitis c - complications (858) 858
hepacivirus - drug effects (841) 841
viruses (833) 833
hepatitis c - transmission (831) 831
abridged index medicus (825) 825
immunology (796) 796
hepatitis c antibodies - blood (795) 795
non-a (779) 779
hepatitis c - immunology (755) 755
liver (753) 753
analysis (733) 733
animals (731) 731
ribavirin - therapeutic use (718) 718
hepatitis-c virus (669) 669
hepatitis c - drug therapy (663) 663
ribavirin (654) 654
sensitivity and specificity (642) 642
genotypes (629) 629
young adult (628) 628
antibodies (617) 617
hiv (611) 611
hepatitis b virus - isolation & purification (608) 608
drug therapy, combination (606) 606
research (597) 597
therapy (597) 597
hepatitis c - blood (592) 592
digestive system diseases (580) 580
genetic aspects (579) 579
replication (576) 576
rna, viral - isolation & purification (570) 570
recombinant proteins (565) 565
non-b-hepatitis (564) 564
epidemiology (542) 542
hepacivirus (542) 542
retrospective studies (537) 537
liver - pathology (520) 520
phylogeny (519) 519
polymerase chain-reaction (513) 513
hepatocellular-carcinoma (512) 512
viral nonstructural proteins - genetics (511) 511
virus-infection (507) 507
genome (492) 492
hepatitis c, chronic - complications (490) 490
enzyme-linked immunosorbent assay (484) 484
alanine transaminase - blood (479) 479
time factors (475) 475
liver - virology (456) 456
antiviral agents - pharmacology (453) 453
reverse transcriptase polymerase chain reaction (453) 453
cell line (451) 451
blood donors (449) 449
antiviral agents (437) 437
proteins (435) 435
hiv infections - complications (431) 431
research article (431) 431
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8521) 8521
Chinese (105) 105
Spanish (92) 92
French (91) 91
Japanese (75) 75
Russian (71) 71
German (33) 33
Hungarian (30) 30
Polish (28) 28
Turkish (13) 13
Italian (10) 10
Korean (9) 9
Dutch (7) 7
Czech (5) 5
Croatian (3) 3
Portuguese (3) 3
Slovak (3) 3
Swedish (3) 3
Romanian (2) 2
Serbian (2) 2
Ukrainian (2) 2
Finnish (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Virology, ISSN 0022-538X, 2017, Volume 91, Issue 1
A recombinant strain HCV1 (hepatitis C virus [HCV] genotype 1a) gpE1/gpE2 (E1E2) vaccine candidate was previously shown by our group to protect chimpanzees and... 
Epitopes | Vaccines | Hepatitis C virus | Neutralizing antibodies | Envelope glycoproteins | vaccines | COMPLEXES | HEPATITIS-C-VIRUS | neutralizing antibodies | REACTIVE NEUTRALIZING ANTIBODIES | HCV INFECTION | E2 ENVELOPE GLYCOPROTEIN | epitopes | IMMUNIZATION | VIROLOGY | envelope glycoproteins | hepatitis C virus | CD81 BINDING | MONOCLONAL-ANTIBODIES | Recombinant Fusion Proteins - isolation & purification | Immune Sera - chemistry | Hepacivirus - immunology | Viral Envelope Proteins - isolation & purification | Viral Hepatitis Vaccines - administration & dosage | Antibodies, Monoclonal - biosynthesis | Humans | Protein Multimerization | Vaccination | Bacterial Proteins - chemistry | Neutralization Tests | Hepacivirus - chemistry | Epitopes - immunology | Hepatitis C - immunology | Hepatitis C - prevention & control | Antibodies, Monoclonal - chemistry | Recombinant Fusion Proteins - biosynthesis | Viral Envelope Proteins - genetics | Chromatography, Agarose - methods | Viral Envelope Proteins - biosynthesis | Hepatitis C Antibodies - chemistry | Antigens, Viral - chemistry | Hepatitis C Antibodies - biosynthesis | Recombinant Fusion Proteins - chemistry | Protein Folding | Cross Reactions | Antigens, Viral - immunology | Immunoglobulin Fc Fragments - isolation & purification | Viral Hepatitis Vaccines - immunology | Animals | Antibodies, Neutralizing - biosynthesis | Antibodies, Neutralizing - chemistry | Hepatitis C - virology | Immunoglobulin Fc Fragments - biosynthesis | Viral Hepatitis Vaccines - biosynthesis | Recombinant Fusion Proteins - genetics | Vaccines, Synthetic | Epitopes - chemistry | Mice | Bacterial Proteins - isolation & purification | Immunoglobulin Fc Fragments - genetics | Index Medicus
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 02/2012, Volume 19, Issue 2, pp. e81 - e88
Journal Article
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive, ISSN 1124-9390, 09/2015, Volume 23, Issue 3, pp. 247 - 252
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 7, pp. 597 - 605
Summary Background Rates of sustained virological response (SVR) to peginterferon–ribavirin are low in patients with hepatitis C virus (HCV) genotype 1 and... 
Infectious Disease | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Recombinant Proteins - adverse effects | Viral Load | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Drug Therapy, Combination - adverse effects | HIV-1 - isolation & purification | Placebos - adverse effects | Ribavirin - administration & dosage | Adult | Female | Placebos - administration & dosage | Proline - administration & dosage | Hepacivirus - isolation & purification | Double-Blind Method | Proline - analogs & derivatives | HIV Infections - virology | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | HIV Infections - complications | Aged | Hepacivirus - classification | Interferon-alpha - adverse effects | Medical colleges | Interferon alpha | Clinical trials | HIV (Viruses) | Biological response modifiers | Ribavirin | Viral antigens | Virus diseases | Genetic aspects | Product development | Drug therapy | Hepatitis C virus | HIV infection | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2011, Volume 108, Issue 27, pp. 11223 - 11228
Hepatitis A virus (HAV) is an hepatotropic human picornavirus that is associated only with acute infection. Its pathogenesis is not well understood because... 
Hepatitis A virus | RNA | Hepatocytes | Viremia | Liver | Viral RNA | Viruses | Infections | Feces | Hepacivirus | Innate immunity | Viral persistence | Immune evasion | CELLS | MULTIDISCIPLINARY SCIENCES | viral persistence | ANTIBODY | REPLICATION | innate immunity | immune evasion | KINETICS | LIVER | C VIRUS | ADAPTER PROTEIN | CHIMPANZEES | ANTIGEN | Liver - virology | Liver - pathology | Humans | Immunity, Innate - genetics | Hepacivirus - genetics | DNA Primers - genetics | Gene Expression Profiling | Host-Pathogen Interactions - immunology | Hepatitis C - immunology | Interferon Type I - biosynthesis | Hepatitis A - genetics | Hepatitis A - immunology | RNA, Viral - genetics | Time Factors | Base Sequence | Hepatitis A - virology | RNA, Viral - isolation & purification | Hepacivirus - isolation & purification | Acute Disease | Gene Expression | Hepatitis A - pathology | Hepatitis A virus - genetics | Hepatitis C - genetics | Pan troglodytes | Animals | Host-Pathogen Interactions - genetics | Hepatitis C - virology | Interferon Type I - genetics | Hepatitis A virus - isolation & purification | Development and progression | Genetic aspects | Interferon | Host-virus relationships | Research | Immunity | Health aspects | Hepatitis A | Hepatitis | Ribonucleic acid--RNA | Gene expression | Monkeys & apes | Viral infections | Index Medicus | Animal models | Immune response | Antibodies | Inflammation | Polymerase chain reaction | Persistent infection | Kinetics | Apoptosis | Biological Sciences
Journal Article
Epidemiology and Infection, ISSN 0950-2688, 06/2018, Volume 146, Issue 8, pp. 1026 - 1035
Journal Article